Summary
We have explored the possibility of using measures of 5-HT (extracellular 5-HT and 5-HIAA in blood) as peripheral indexes of MAO activity. Depressed patients treated with phenelzine for 6 weeks display a dramatic increase of plasma 5-HT (270% of basal values) together with a decrease of plasma 5-HIAA. After treatment with irreversible MAO inhibitors, rat plasma 5-HIAA decreased in a similar fashion than MAO-A activity in liver, lungs and brain, measured using 5-HT as substrate. These results support the use of plasma 5-HT and 5-HIAA in humans to evaluate the action of MAOI on the serotonergic system.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Artigas F, Sarrias MJ, Martínez E, Gelpí E (1985) Serotonin in body fluids. Characterization of human plasmatic and cerebrospinal fluid pools by means of a new HPLC method. Life Sci 37:441–447.
Artigas F, Sarrias MJ, Martínez E, Gelpí E, Alvarez E, Udina C (1989) Increased plasma serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium. Psychopharmacology 99:328–332.
Åsberg M, Thoren P, Traskman L, Bertilsson L, Reingberger V (1976) “Serotonin depression” — A biochemical subgroup within the affective disorders?. Science 191:478–480.
Cooper AJ (1989) Tyramine and irreversible monoamine oxidase inhibitors in clinical practice. Br J Psychiatry 155:38–45.
Donnelly CH, Murphy DL (1977) Substrate and inhibitor-related characteristics of human platelet monoamine oxidase. Biochem Pharmacol 26:852–858.
Gillis CN (1985) Peripheral metabolism of serotonin. In: Vanhoutte PM (ed) Serotonin and the cardiovascular system. Raven Press, New York, pp 27–36.
Heninger GR, Charney DS, Sternberg DE (1984) Serotonergic function in depression: prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Arch Gen Psychiatry 41:398–402.
Heninger GR, Charney DS (1987) Mechanism of action of antidepressant treatments: implications for the etiology and treatment of depressive disorders. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 535–544.
Ortiz J, Artigas F Gelpí E (1988) Serotonergic status in human blood. Life Sci 43:983–990.
Paykel ES, White JL (1989) A European study of views on the use of monoamine oxidase inhibitors. Br J Psychiatry 155:9–17.
Sarrias MJ, Artigas F, Martínez E, Gelpí E, Alvarez E, Udina C, Casas M (1987) Decreased plasma serotonin in melancholic patients: a study with clomipramine. Biol Psychiatry 22:1429–1438.
Young WF, Laws ER, Sharbrough FW, Weinshilboum RM (1986) Human monoamine oxidase. Lack of brain and platelet correlation. Arch Gen Psychiatry 43:604–609.
Zimmerman HJ, Ishak KG (1987) The hepatic injury of monoamine oxidase inhibitors. J Clin Psychopharmacol 7:211–213.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag
About this paper
Cite this paper
Celada, P., Sarrias, M.J., Artigas, F. (1990). Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity. In: Riederer, P., Youdim, M.B.H. (eds) Amine Oxidases and Their Impact on Neurobiology. Journal of Neural Transmission, vol 32. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9113-2_21
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9113-2_21
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82239-5
Online ISBN: 978-3-7091-9113-2
eBook Packages: Springer Book Archive